Lead and cadmium are non-essential and toxic heavy metals. Their presence and elevated levels can lead to many pathologies. They disrupt the antioxidant properties of many enzymes, consume the resources of antioxidant cells, and thus participate in the generation of oxidative stress, which may result in DNA damage. In addition, they have been found to be carcinogenic through their genotoxic properties. They have been shown to be present in various types of cancer, including cancer of the female reproductive system. Both metals have been recognized as metalloestrogens, which are important in hormone-related cancers. Participation in the oncogenesis of ovarian, endometrial and cervical cancer was analysed in detail, using the available research in this field. We emphasize their role as potential biomarkers in cancer risk and diagnosis as well as advancement of gynaecological malignancies.
Anxiety is a subjective feeling of fear in response to stressful or threatening situations. Chronic diseases (such as chronic kidney disease) or the state after kidney transplantation are such situations and they may result in a decreased quality of life. The main aim of this research was to evaluate if the proteins IL-8, RANTES, MIG, MCP-1, IP-10, and IL-12p70 could be indicators of higher levels of anxiety or decreased quality of life in chronically ill women. The assessment was conducted using the STAI and SF-36 questionnaires and with the measurement of listed proteins from the patient’s blood sample. The study group consisted of 107 women—101 patients from the Nephrological Clinic and 6 from the Dialysis Center. Both of the facilities are part of University Clinical Hospital No. 2 in Szczecin. Statistical analysis was performed using JASP software (JASP 0.18.3 version). Anxiety levels and quality of life correlations between STAI and SF-36 scores and individual variables were assessed. Logistic regression models were performed for both questionnaire outcomes: SF-36 and STAI. Lower quality of life was found in the group with a higher IL-8 concentration compared to the group of women with a lower IL-8 concentration. A positive weak correlation was found between a decreased quality of life and IL-8 and RANTES. A higher RANTES level increases the odds of a lower quality of life. This study shows that special care should be provided for chronically ill women (especially with CKD or after KTx) with a higher RANTES or IL-8 concentration. They would highly benefit from close monitoring of their mental health.
2 December 2025 in JITSS (Journal of Innovation and Trend in Social Sciences)
Phosphodiesterase type 5 inhibitors (PDE5Is) are widely prescribed for erectile dysfunction; however, growing evidence indicates that their pharmacological effects extend beyond urological indications and involve multiple organ systems. This narrative review aims to synthesize and critically evaluate current evidence on the systemic effects of PDE5 inhibitors across cardiovascular, renal, neurological, and urological domains, as well as emerging therapeutic indications. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science for studies published up to May 2024, including preclinical studies, clinical trials, observational studies, systematic reviews, and meta-analyses. The reviewed evidence demonstrates that PDE5 inhibitors are associated with reduced cardiovascular morbidity and mortality, improvements in cardiac and pulmonary hemodynamics, preservation of renal function in diabetic populations, potential neuroprotective effects against cognitive decline and ischemic stroke, and symptomatic improvement in benign prostatic hyperplasia and lower urinary tract symptoms. Additional benefits have been reported in conditions characterized by vascular dysfunction, such as angina pectoris and Raynaud’s phenomenon. Overall, PDE5 inhibitors represent a pharmacologically versatile drug class with clinically relevant systemic effects beyond erectile dysfunction, supporting their potential role as adjunctive therapies in broader disease management, although further well-designed randomized controlled trials are needed to inform clinical guidelines.
Background and Clinical Significance: In a single phenotypically female patient, we describe the rare co-occurrence of partial androgen insensitivity syndrome (PAIS) and congenital adrenal hyperplasia (CAH). Partial androgen insensitivity syndrome (PAIS) is one of disorder of sex development (DSD) with a 46 XY karyotype. Congenital adrenal hyperplasia (CAH) is a genetic defect in adrenal steroidogenesis. Case presentation: We present the case of a 26-year-old female patient who was observed to have abnormally formed external genitourinary organs. She was diagnosed at the neonatal period. Tests performed showed a 46 XY karyotype, an absence of sex chromatin with a weakly positive DNA test for the SRY gene, an absence of uterine primordium with the presence of male gonads in the perineal skin folds, and a urethral outlet at the base of an undeveloped genital process. The daily urinary steroid excretion profile was normal. The patient was diagnosed with partial androgen insensitivity syndrome (PAIS). As a 4-year-old child, she underwent a bilateral gonadectomy due to possible further virilization and also the risk of testicular malignancy. Despite treatment, progressive androgenization was observed, the cause of which turned out to be congenital adrenal hyperplasia (CAH) in the course of P450 oxidoreductase (POR) disorder. Conclusions: In this article, we highlight the exceptional rarity of the co-occurrence of PAIS and CAH, underscoring the need for a multidisciplinary and individualized approach in the absence of clear guidelines regarding surgical timing and gender identity. Careful clinical evaluation and ongoing observation are essential for accurate diagnosis and optimal patient care.
19 November 2025 in International Journal of Innovative Technologies in Social Science
Background. Physical activity is a key lifestyle factor influencing fertility. As more women delay pregnancy, it's important they understand which modifiable factors can impact their reproductive health. Aim. The aim of this article is to give women more accurate information. Present the data that is currently available to demonstrate how often, how intense, and which exercises are ideal for their reproductive system health when they participate in a sport that will help them keep or improve their fertility. Material and methods. A comprehensive literature search was conducted using PubMed, GoogleScholar, and WebScience databases, focusing on the following keywords: female fertility, physical activity, reproduction health, lifestyle factors and exercise. The search covered publications from 2002 to 2025. Results. Light to moderate physical activity (6 METs) improves ovulation and conception rates in overweight or obese women. However, prolonged intense exercise combined with a low-calorie diet can disrupt the hypothalamic-pituitary-gonadal axis, leading to irregular periods, anovulation, or secondary amenorrhea. Conclusions. One significant and modifiable component in the control and improvement of female fertility should be physical activity. However, light to moderate exercise is good for you and should be promoted, especially for women who have metabolic disorders or lead sedentary lives. The vigorous exercise may have a detrimental effect on reproductive health, apart from women who are overweight or obese.
30 September 2025 in International Journal of Innovative Technologies in Social Science
Background: Regular physical activity and exercise during pregnancy, in the absence of contraindications, is recommended and recognized as safe and beneficial for both the mother and the developing fetus. However, contact sports, where the risk of injury is significantly higher, should be avoided. The peripartum period is considered a significant risk factor for the development of mental health issues, particularly postpartum depression (PPD). Aim: This review first presents aspects of the changes in physiology in the mother and fetus. Then the risks and contraindications are discussed, and the various forms of activity are briefly described about their safety, including pelvic-floor muscle exercises and their impact on the course of labor as well as recovery afterwards. Material and methods: Studies, clinical trials, meta-analyses and systematic reviews with quantifiable or qualitative sports and physical activity during pregnancy data. Results: There is now plenty of evidence for the beneficial effects of moderate exercise during pregnancy, even in previously inactive women. Conclusions: Exercise can help reduce the risk of gestational diabetes, pre-eclampsia and cesarean section, while preventing excessive weight gain especially in obese patients. A reduced incidence of postpartum depression has been associated with returning to physical exercise and sports after pregnancy.